RxDoctor Payments Data

Ron Karni, MD

Otolaryngology · Houston, TXNPI 1053434910

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (54.9%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Tactile Systems Technology Inc accounts for 80.1% of it on its own, with 13 other manufacturers making up the rest. Among otolaryngology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$316,791in general payments, 2019–2025

Across 393 payments — averaging $806.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Tactile Systems Technology Inc$254K
  • Johnson & Johnson$28K
  • Covidien LP$22K
  • Medical Device Business Services, Inc.$4K
  • Medtronic$3K
  • Omniguide, Inc.$2K
  • plus $4K from 8 others
$19,600in research payments, 2019–2025

Across 1 payment — averaging $19,600 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Tactile Systems Technology Inc$20K

What the payments were for

  • Consulting fees$65,06621%
  • Speaking & faculty fees$174,07155%
  • Travel & lodging$66,92221%
  • Food & beverage$10,4763%
  • Education$2560%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$316,791 in reported general payments places this provider in the 95th percentile of 729 otolaryngology providers in Texas.

See all otolaryngology providers in Texas

Medicare billing

Part B allowed, 2024
$220,068
Medicare patients
317
Services billed
889

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen279$2,061
Gabapentin65$990
Azelastine Hcl31$986
Omeprazole78$651
SynthroidLevothyroxine Sodium12$559
Albuterol Sulfate HfaAlbuterol Sulfate20$482
Levothyroxine Sodium77$336
Triamcinolone Acetonide13$326
Ofloxacin13$277
Ipratropium Bromide11$273
Nystatin11$135
Lidocaine Hcl ViscousLidocaine Hcl18$121
Prednisone55$49
Tramadol Hcl14$43

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →